Carcinoma of the breast during estrogen replacement therapy.
D000328:Adult; D000368:Aged; D001941:Breast Diseases; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000473:pathology; D002277:Carcinoma / Q000139:chemically induced*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000139:chemically induced* / Q000473:pathology; D003550:Cystic Fibrosis; D004958:Estradiol / Q000009:adverse effects; D004964:Estriol / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects; D004970:Estrone / Q000009:adverse effects; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged
D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D004970:Estrone; D004958:Estradiol; D004964:Estriol